APA (7th ed.) Citation

S, A., E, O., A, P., RD, P., & AA, C. (2026). Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia. Drug safety. https://doi.org/10.1007/s40264-026-01678-2

Chicago Style (17th ed.) Citation

S, Ailawadhi, Omercikoglu E, Paulus A, Parrondo RD, and Chanan-Khan AA. "Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia." Drug Safety 2026. https://doi.org/10.1007/s40264-026-01678-2.

MLA (9th ed.) Citation

S, Ailawadhi, et al. "Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia." Drug Safety, 2026, https://doi.org/10.1007/s40264-026-01678-2.